Vicapsys Life Sciences, Inc. (VICP)
0.50
0.00 (0.00%)
USD |
OTCM |
Nov 12, 16:00
Vicapsys Life Sciences Free Cash Flow (Quarterly) : -0.0051M for March 31, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0051M |
| March 31, 2025 | -0.0057M |
| December 31, 2024 | -0.078M |
| September 30, 2024 | -0.0404M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | -0.0033M |
| December 31, 2023 | 0.0206M |
| September 30, 2023 | -0.1596M |
| June 30, 2023 | -0.2181M |
| March 31, 2023 | -0.01M |
| December 31, 2022 | 0.0029M |
| September 30, 2022 | -0.0411M |
| June 30, 2022 | -0.084M |
| March 31, 2022 | -0.116M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.1233M |
| September 30, 2021 | -0.1801M |
| June 30, 2021 | -0.0698M |
| March 31, 2021 | -0.0708M |
| December 31, 2020 | -0.0004M |
| September 30, 2020 | -0.0033M |
| June 30, 2020 | -0.026M |
| March 31, 2020 | -0.2332M |
| December 31, 2019 | |
| June 30, 2019 | |
| December 31, 2018 | |
| March 31, 2010 | 0.263M |
| March 31, 2009 | -0.4593M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.30M |
| Sarepta Therapeutics, Inc. | 53.83M |
| Anixa Biosciences, Inc. | -1.77M |